Belgium · 
Who invested in Coultreon Biopharma?
Coultreon Biopharma's investors include Novo Holdings, Samsara BioCapital and Longwood Fund.
Belgium · Series A startup
Who invested in Coultreon Biopharma
Funding summaryUpdated 26 Oct 2026
$125Mraised across 1 round since 2026, from 1 source
- Latest round
- Series A, $125MApr 2026
- Investors
- 3
The rounds
- Apr 2026
Founders and team
From Coultreon Biopharma's own website: 3 founders, 13 on the team.
François GonzalvezCo-founder
Joost KolkmanCo-founder
Sandrine VendevilleCo-founder
- Pierre RaboissonChief Executive Officer
- Guy PeetersChief Financial Officer
- Marie De VulderChief Legal Officer
- Nate MassariChief Business Officer
- Prista CharuwornChief Medical Officer
- Fabrice KolbHead of Immunology
- Gert De BeckkerHead of Regulatory
- John-Paul GallivanHead of Development
- Lawrence BlattBoard member
- Maha KatabiBoard member
- Max KlementBoard member
- Pieter PeetersOperating & Technology Officer
- Rogier RooswinkelBoard member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Coultreon Biopharma
How much has Coultreon Biopharma raised?
Coultreon Biopharma has raised $125M across 1 round since 2026.
When did Coultreon Biopharma last raise?
Coultreon Biopharma's most recent round was a Series A of $125M in Apr 2026.
What was Coultreon Biopharma's biggest round?
Its most recent round, $125M in Apr 2026, is also its largest on record.
Who backed Coultreon Biopharma first?
Coultreon Biopharma's first round on record, in Apr 2026, was backed by Novo Holdings, Samsara BioCapital and Longwood Fund.
What stage is Coultreon Biopharma at?
Coultreon Biopharma's latest named round is a Series A, in Apr 2026.
Where is Coultreon Biopharma based?
Coultreon Biopharma is based in Belgium.
Companies like Coultreon Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.